CTMX insider trading

Open-market stock trades by CytomX Therapeutics (CTMX) executives and directors: who bought or sold, how many shares, at what price and when.

CTMX insider trades

DateInsiderRoleTradeSharesPriceValue
Nov 6, 2025McCarthy Sean A.CEOSell101,793$4.54$461.91K
Jun 15, 2026Ogden ChristopherChief Financial OfficerSell1,624$3.05$4.95K
Mar 17, 2026Chu Yu-WayeChief Medical OfficerSell21,279$6.42$136.68K
Mar 17, 2026McCarthy Sean A.CEOSell118,969$6.42$764.14K
Mar 17, 2026BELVIN MARCIASVP, Chief Scientific OfficerSell31,492$6.42$202.27K
Mar 17, 2026Ogden ChristopherChief Financial OfficerSell19,323$6.42$124.11K
Nov 6, 2025McCarthy Sean A.CEOSell101,793$4.54$461.91K
Jun 16, 2025Ogden ChristopherChief Financial OfficerSell10,614$2.69$28.54K
Jun 13, 2025Ogden ChristopherChief Financial OfficerSell1,641$2.95$4.84K
Jun 16, 2025BELVIN MARCIASVP, Chief Scientific OfficerSell13,884$2.69$37.33K
Jun 16, 2025McCarthy Sean A.CEOSell55,511$2.69$149.26K
Mar 18, 2025McCarthy Sean A.CEOSell37,656$0.60$22.56K
Mar 18, 2025Ogden ChristopherChief Financial OfficerSell8,551$0.60$5.12K
Mar 18, 2025Chu Yu-WayeChief Medical OfficerSell4,025$0.60$2.41K
Mar 18, 2025ROWLAND LLOYD AGeneral CounselSell10,203$0.60$6.11K
Mar 18, 2025BELVIN MARCIASVP, Chief Scientific OfficerSell19,512$0.60$11.69K
Aug 20, 2024Landau Jeffrey BChief Business OfficerSell4,181$1.23$5.14K
Aug 20, 2024BELVIN MARCIASVP, Chief Scientific OfficerSell4,181$1.23$5.14K
Aug 20, 2024ROWLAND LLOYD AGeneral CounselSell4,181$1.23$5.14K
Aug 20, 2024Ogden ChristopherChief Financial OfficerSell1,984$1.23$2.44K
Aug 20, 2024McCarthy Sean A.CEOSell13,898$1.23$17.08K

Updated 2026-11-02 17:53 UTC